Found: 34
Select item for more details and to access through your institution.
Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumors.
- Published in:
- Acta Neuropathologica Communications, 2024, v. 12, n. 1, p. 1, doi. 10.1186/s40478-024-01846-4
- By:
- Publication type:
- Article
Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Immune biomarkers and response to checkpoint inhibition of BRAF<sup>V600</sup> and BRAF non-V600 altered lung cancers.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The Impact of Cigarette Smoking on the Frequency of and Qualitative Differences in KRAS Mutations in Korean Patients with Lung Adenocarcinoma.
- Published in:
- Yonsei Medical Journal, 2013, v. 54, n. 4, p. 865, doi. 10.3349/ymj.2013.54.4.865
- By:
- Publication type:
- Article
Single-Cell Sequencing Illuminates Thymic Development: An Updated Framework for Understanding Thymic Epithelial Tumors.
- Published in:
- Oncologist, 2024, v. 29, n. 6, p. 473, doi. 10.1093/oncolo/oyae046
- By:
- Publication type:
- Article
Outcomes of Combination Platinum-Doublet Chemotherapy and Anti-PD(L)-1 Blockade in KRAS<sup>G12C</sup>-Mutant Non-Small Cell Lung Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 11, p. 978, doi. 10.1093/oncolo/oyad197
- By:
- Publication type:
- Article
Management of thymoma‐associated pure red cell aplasia: A novel use of blood substitute HBOC‐201 in a Jehovah's Witness.
- Published in:
- Clinical Case Reports, 2020, v. 8, n. 2, p. 289, doi. 10.1002/ccr3.2626
- By:
- Publication type:
- Article
The Use of Antiangiogenic Agents for Lung Cancer in Elderly Patients: An Expert Panel Discussion Synopsis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Lessons learned from routine, targeted assessment of liquid biopsies for EGFR T790M resistance mutation in patients with EGFR mutant lung cancers.
- Published in:
- Acta Oncologica, 2019, v. 58, n. 11, p. 1634, doi. 10.1080/0284186X.2019.1645354
- By:
- Publication type:
- Article
Frequency and outcomes of brain metastases in patients with HER2-mutant lung cancers.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain.
- Published in:
- PLoS Medicine, 2005, v. 2, n. 3, p. 225, doi. 10.1371/journal.pmed.0020073
- By:
- Publication type:
- Article
KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib.
- Published in:
- PLoS Medicine, 2005, v. 2, n. 1, p. 57, doi. 10.1371/journal.pmed.0020017
- By:
- Publication type:
- Article
Structural, Biochemical, and Clinical Characterization of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations in Lung Cancer.
- Published in:
- Science Translational Medicine, 2013, v. 5, n. 216, p. 1, doi. 10.1126/scitranslmed.3007205
- By:
- Publication type:
- Article
Chemotherapy Definitions and Policies for Thymic Malignancies.
- Published in:
- Chinese Journal of Lung Cancer, 2014, v. 17, n. 2, p. 116, doi. 10.3779/j.issn.1009-3419.2014.02.09
- By:
- Publication type:
- Article
Improving therapy for patients with epidermal growth factor receptor-mutant lung cancer.
- Published in:
- 2018
- By:
- Publication type:
- editorial
Twice weekly pulse and daily continuous-dose erlotinib as initial treatment for patients with epidermal growth factor receptor-mutant lung cancers and brain metastases.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Epidermal growth factor receptor exon 20 insertions in advanced lung adenocarcinomas: Clinical outcomes and response to erlotinib.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 18, p. 3212, doi. 10.1002/cncr.29493
- By:
- Publication type:
- Article
Differences in the survival of patients with recurrent versus de novo metastatic KRAS-mutant and EGFR-mutant lung adenocarcinomas.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 12, p. 2078, doi. 10.1002/cncr.29313
- By:
- Publication type:
- Article
Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinomas.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 2, p. 356, doi. 10.1002/cncr.27730
- By:
- Publication type:
- Article
Driver mutations determine survival in smokers and never-smokers with stage IIIB/IV lung adenocarcinomas.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 23, p. 5840, doi. 10.1002/cncr.27637
- By:
- Publication type:
- Article
Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancer.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Pack-Years of Cigarette Smoking as a Prognostic Factor in Patients With Stage IIIB/ IV Nonsmall Cell Lung Cancer.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 3, p. 670, doi. 10.1002/cncr.24813
- By:
- Publication type:
- Article
Phase 1 Trial of Everolimus and Gefitinib in Patients With Advanced Nonsmall-Cell Lung Cancer.
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 3, p. 599, doi. 10.1002/cncr.22816
- By:
- Publication type:
- Article
Serplulimab With Chemotherapy in Extensive-Stage SCLC.
- Published in:
- JAMA: Journal of the American Medical Association, 2022, v. 328, n. 12, p. 1205, doi. 10.1001/jama.2022.16442
- By:
- Publication type:
- Article
Expression of PD-L1 and other immunotherapeutic targets in thymic epithelial tumors.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0182665
- By:
- Publication type:
- Article
Lung Cancer in 'Never-Smokers': Molecular Factors Trump Risk Factors.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 1, p. 38
- By:
- Publication type:
- Article
A phase 2 study of weekly albumin-bound paclitaxel (Abraxane®) given as a two-hour infusion.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Validation of a Population-Based Data Source to Examine National Cancer Clinical Trial Participation.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 3, p. e223687, doi. 10.1001/jamanetworkopen.2022.3687
- By:
- Publication type:
- Article
Correlation Between Surrogate End Points and Overall Survival in a Multi-institutional Clinicogenomic Cohort of Patients With Non–Small Cell Lung or Colorectal Cancer.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 7, p. e2117547, doi. 10.1001/jamanetworkopen.2021.17547
- By:
- Publication type:
- Article
Mobocertinib (TAK-788) in EGFR Exon 20 Insertion+ Metastatic NSCLC: Patient-Reported Outcomes from EXCLAIM Extension Cohort.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 1, p. 112, doi. 10.3390/jcm12010112
- By:
- Publication type:
- Article
A Genomic-Pathologic Annotated Risk Model to Predict Recurrence in Early-Stage Lung Adenocarcinoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Emerging Science and Therapies in Non-small-Cell Lung Cancer: Targeting the MET Pathway.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 6, p. 475, doi. 10.1016/j.cllc.2014.08.001
- By:
- Publication type:
- Article
Type A thymoma presenting with bone metastasis.
- Published in:
- 2018
- By:
- Publication type:
- Case Study